The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (3), 497-529
- https://doi.org/10.1053/beha.2001.0152
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialBritish Journal of Haematology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implicationsOncogene, 1999
- The Signal Transducer and Activator of Transcription STAT5b Gene Is a New Partner of Retinoic Acid Receptor in Acute Promyelocytic-Like LeukaemiaHuman Molecular Genetics, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trialsBritish Journal of Haematology, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemiaBritish Journal of Haematology, 1997
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983